SCHEMBL3046221

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL478902	1.00	ACHE (0.50)	ACHEBACE1CA2MAPK1HCAR2
	SCHEMBL8052122	0.80	GABRP (0.41)	ACHEBACE1HCAR2GABRPGABRD
	SCHEMBL28910435	0.80	ACHE (0.45)	ACHEBACE1HCAR2GPR84ZDHHC20
	SCHEMBL8090945	0.75	ACHE (0.76)	ACHEBACE1
	SCHEMBL8965243	0.75	ACHE (0.55)	ACHEBACE1CA2MAPK1HCAR2
	SCHEMBL8828842	0.75	ACHE (0.76)	ACHEBACE1
	SCHEMBL8965248	0.75	ACHE (0.55)	ACHEBACE1CA2MAPK1HCAR2
	SCHEMBL4826149	0.73	ACHE (0.53)	ACHEBACE1CA2MAPK1HCAR2
	SCHEMBL2893103	0.73	ACHE (0.53)	ACHEBACE1CA2MAPK1HCAR2
	SCHEMBL11072371	0.73	ACHE (0.53)	ACHEBACE1CA2MAPK1HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.